MedMen Enterprises Inc. (MMNFF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MedMen Enterprises Inc. (MMNFF) trades at $0.00 with AI Score 43/100 (Grade C). MedMen Enterprises Inc. cultivates, produces, distributes, and retails recreational and medicinal cannabis in the United States. Market cap: $138,320, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for MMNFF: MMNFF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MMNFF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MMNFF: the 1 perspectives are evenly split.
How is this calculated? →MedMen Enterprises Inc. (MMNFF) Healthcare & Pipeline Overview
MedMen Enterprises Inc. is a cannabis company operating in the United States, focusing on cultivation, production, distribution, and retail of recreational and medicinal cannabis. With a presence in key states, MedMen competes in a rapidly evolving market landscape with a negative profit margin of -117.6%.
What Is the Investment Thesis for MMNFF?
MedMen Enterprises Inc. operates in the rapidly growing cannabis industry but faces significant financial challenges. With a negative P/E ratio and a profit margin of -117.6%, the company's profitability is a major concern. The company's gross margin of 49.5% indicates potential in its core operations, but high operating expenses are hindering overall profitability. Key growth catalysts include expansion into new markets and increased legalization of cannabis. However, the company's high beta of 1.40 suggests significant volatility. Investors should closely monitor MedMen's ability to improve its financial performance and navigate the competitive landscape. The company's success depends on effective execution of its growth strategy and efficient management of its operations.
Based on FMP financials and quantitative analysis
MMNFF Key Highlights
- Operates 29 stores across multiple states as of December 25, 2021, indicating a substantial retail presence.
- Cultivates, produces, distributes, and retails recreational and medicinal cannabis, offering a vertically integrated business model.
- Gross margin of 49.5% suggests potential for profitability if operating expenses are managed effectively.
- Negative profit margin of -117.6% highlights significant financial challenges and the need for improved cost management.
- High beta of 1.40 indicates significant volatility, reflecting the speculative nature of the cannabis industry.
Who Are MMNFF's Competitors?
MMNFF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| SGIOY Shionogi & Co., Ltd. | $8.97 | +3.70% | $15.27B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MMNFF's Key Strengths?
- Established brand recognition in the cannabis industry.
- Vertically integrated operations provide control over the supply chain.
- Retail footprint in key cannabis markets.
- Focus on premium branding and high-quality products.
What Are MMNFF's Weaknesses?
- Negative profit margin and significant financial losses.
- High operating expenses.
- Intense competition in the cannabis industry.
- Regulatory uncertainty and evolving state-level laws.
What Could Drive MMNFF Stock Higher?
- Potential for expansion into new markets as more states legalize cannabis.
- Increasing consumer acceptance of cannabis and growing demand for cannabis products.
- Product innovation and development of new cannabis strains and products.
What Are the Key Risks for MMNFF?
- Financial-distress signal — its Altman Z-Score of -9.55 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-96.4%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition in the cannabis industry.
- Regulatory changes and stricter enforcement of cannabis laws.
- Financial losses and negative profit margin.
- Economic downturns that could reduce consumer spending on cannabis.
- Limited financial disclosure due to OTC listing.
What Are the Growth Opportunities for MMNFF?
- Expansion into New Markets: As more states legalize cannabis for recreational and medicinal use, MedMen has the opportunity to expand its retail footprint and cultivation operations into new markets. This expansion can drive revenue growth and increase market share. The timeline for this growth depends on the pace of legalization in different states, but the long-term potential is significant. Successfully entering new markets requires navigating complex regulatory frameworks and establishing strong local partnerships.
- Increased Legalization of Cannabis: The ongoing trend of cannabis legalization at the state and federal levels presents a significant growth opportunity for MedMen. As more states legalize cannabis, the market size expands, and MedMen can reach a larger customer base. The timeline for this growth is dependent on legislative changes, but the overall trend is positive. Federal legalization would be a major catalyst, opening up interstate commerce and reducing regulatory burdens.
- Product Innovation and Branding: MedMen can drive growth by developing new and innovative cannabis products that cater to evolving consumer preferences. This includes creating new strains, edibles, and other cannabis-infused products. Building a strong brand reputation for quality and consistency is also crucial for attracting and retaining customers. The timeline for this growth is ongoing, as MedMen continuously invests in research and development and marketing efforts.
- Enhancing Retail Experience: MedMen can differentiate itself from competitors by providing a superior retail experience. This includes creating visually appealing stores, offering knowledgeable and friendly customer service, and providing a wide selection of high-quality products. Enhancing the retail experience can attract more customers and increase sales. The timeline for this growth is ongoing, as MedMen continuously invests in improving its store design and customer service.
- Strategic Partnerships and Acquisitions: MedMen can accelerate its growth through strategic partnerships and acquisitions. This includes partnering with other cannabis companies to expand its product offerings or entering into joint ventures to enter new markets. Acquisitions can provide MedMen with access to new technologies, brands, or retail locations. The timeline for this growth is opportunistic, as MedMen evaluates potential partnerships and acquisitions on an ongoing basis.
What Opportunities Does MMNFF Have?
- Expansion into new markets as more states legalize cannabis.
- Increased legalization of cannabis at the federal level.
- Product innovation and development of new cannabis products.
- Strategic partnerships and acquisitions to expand market reach.
What Threats Does MMNFF Face?
- Increased competition from other cannabis companies.
- Changing consumer preferences and demand for different cannabis products.
- Regulatory changes and stricter enforcement of cannabis laws.
- Economic downturns that could reduce consumer spending on cannabis.
What Are MMNFF's Competitive Advantages?
- Brand recognition: MedMen has established a well-known brand in the cannabis industry.
- Retail footprint: Operates a network of retail stores in key markets.
- Vertically integrated operations: Controls the entire supply chain from cultivation to retail.
- Proprietary strains and products: Develops unique cannabis strains and products.
What Does MMNFF Do?
MedMen Enterprises Inc. was founded with the vision of mainstreaming cannabis and setting a new standard for the cannabis industry. The company cultivates, produces, distributes, and retails recreational and medicinal cannabis products. MedMen's brands include MedMen Red and LuxLyte, catering to different consumer segments within the cannabis market. As of December 25, 2021, MedMen operated 29 stores across California, Florida, Nevada, Illinois, Arizona, Massachusetts, and New York. The company is headquartered in Culver City, California. MedMen aims to provide a premium retail experience and high-quality cannabis products, focusing on compliance and responsible operations. However, the company faces significant challenges, including financial losses and intense competition in the evolving cannabis market. The company's strategy involves expanding its retail footprint, enhancing its brand portfolio, and optimizing its supply chain to improve profitability and market share. MedMen's focus on key markets like California and Florida reflects its strategy to capitalize on high-growth opportunities in the cannabis sector.
What Products and Services Does MMNFF Offer?
- Cultivates cannabis plants.
- Produces cannabis products, including flower, edibles, and concentrates.
- Distributes cannabis products to its retail stores.
- Operates retail stores that sell recreational and medicinal cannabis.
- Markets and brands its cannabis products under the MedMen Red and LuxLyte brands.
- Ensures compliance with state and local regulations.
- Provides customer service and education about cannabis products.
How Does MMNFF Make Money?
- Vertically integrated: controls cultivation, production, distribution, and retail.
- Generates revenue through the sale of cannabis products in its retail stores.
- Focuses on premium branding and high-quality products.
- Operates in states with legal recreational and/or medicinal cannabis markets.
What Industry Does MMNFF Operate In?
MedMen operates in the rapidly expanding cannabis industry, driven by increasing legalization and changing consumer attitudes. The market is characterized by intense competition, evolving regulations, and varying state-level laws. Companies like MedMen are vying for market share in key states such as California, Florida, and Illinois. The industry is projected to continue growing, with estimates varying widely depending on regulatory changes and market adoption. MedMen's ability to navigate this complex landscape and differentiate itself through branding, product quality, and retail experience will be crucial for its success.
Who Are MMNFF's Key Customers?
- Adults aged 21 and over seeking recreational cannabis products.
- Patients with medical conditions who are authorized to use medicinal cannabis.
- Cannabis connoisseurs seeking high-quality and unique products.
- Tourists visiting states with legal cannabis markets.
How MedMen Enterprises Inc. Is Valued
MedMen Enterprises Inc. carries a market capitalization of 138K, placing it in the micro-cap category. Relative to its peer group, MMNFF's quantitative score of 43/100 is below the peer average of 66/100.
ROE -96%Key Financial Metrics
Return on equity for MedMen Enterprises Inc. stands at -96.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -51.2%, showing how much profit it generates from its asset base. A current ratio of 0.49 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 3/9Financial Health
MedMen Enterprises Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -9.55 places it in the distress zone, a signal of elevated financial risk.
MMNFF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in MedMen's recovery and future growth potential.
- Community sentiment has shifted positively, with increased discussions around the cannabis sector's legalization trends.
- The company's focus on strategic partnerships may enhance its market positioning and operational efficiency.
- Positive media coverage highlighting MedMen's innovative product offerings has boosted brand visibility and consumer interest.
Bear Case
- Concerns over regulatory uncertainties in the cannabis industry may hinder growth prospects and investor confidence.
- Recent bearish sentiment in online forums reflects skepticism about MedMen's ability to achieve profitability in a competitive market.
- Ongoing financial challenges and debt levels raise questions about the company's long-term sustainability.
- Market perception remains cautious due to broader economic factors affecting the cannabis industry, including potential tax implications.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
MMNFF Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Lows On Tuesday
· Feb 11, 2020
MMNFF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MMNFF.
Price Targets
Wall Street price target analysis for MMNFF.
MMNFF MoonshotScore
What does this score mean?
The MoonshotScore rates MMNFF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Melony Valleau CPA
Unknown
Melony Valleau is a CPA who is managing 428 employees at MedMen Enterprises Inc. More information about her background, career history, education, and previous roles is not available in the provided data. Her expertise as a CPA likely brings financial acumen to the leadership role within the company, which is particularly important given the company's current financial challenges.
Track Record: Due to limited information, Melony Valleau's specific achievements, strategic decisions, and company milestones under her leadership cannot be assessed. Her impact on the company's performance and strategic direction remains unknown based on the available data.
MMNFF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that MedMen Enterprises Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries higher risks due to the lack of regulatory oversight and potential for fraud or manipulation. This tier is often populated by shell companies, bankrupt entities, or companies with questionable business practices.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in MMNFF.
- Low liquidity can make it difficult to buy or sell shares.
- Higher potential for fraud or manipulation on the OTC Other tier.
- Lack of regulatory oversight compared to major exchanges.
- Potential for delisting or trading suspension.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any history of regulatory actions or legal disputes.
- Operation of 29 stores in multiple states as of December 25, 2021.
- Cultivation, production, distribution, and retail of cannabis products.
- Established brands (MedMen Red and LuxLyte).
- Presence in a regulated industry (cannabis).
- Managing 428 employees.
Common Questions About MMNFF (Healthcare)
What does MedMen Enterprises Inc. do?
MedMen Enterprises Inc. operates as a cannabis company in the United States, focusing on the cultivation, production, distribution, and retail of recreational and medicinal cannabis. The company manages a chain of retail stores under the MedMen Red and LuxLyte brand names, offering a range of cannabis products to consumers and patients. MedMen aims to provide a premium retail experience and high-quality cannabis products, while navigating the complex regulatory landscape of the cannabis industry. The company's vertically integrated business model allows it to control the entire supply chain, from cultivation to retail sales.
What do analysts say about MMNFF stock?
Based on available data, there is no analyst coverage information provided for MMNFF stock. Given that it trades on the OTC market, particularly the OTC Other tier, it is less likely to have extensive analyst coverage compared to companies listed on major exchanges like the NYSE or NASDAQ. Investors should conduct their own thorough research and due diligence before investing in MMNFF, considering the limited availability of analyst opinions and financial information.
What are the main risks for MMNFF?
MedMen Enterprises Inc. faces several significant risks, including intense competition in the cannabis industry, regulatory uncertainty and evolving state-level laws, and ongoing financial losses with a negative profit margin. The company's listing on the OTC Other tier also presents risks related to limited financial disclosure, low liquidity, and potential for fraud or manipulation. Economic downturns could reduce consumer spending on cannabis, impacting MedMen's revenue. Investors should carefully consider these risks before investing in MMNFF.
What are the key factors to evaluate for MMNFF?
MedMen Enterprises Inc. (MMNFF) holds an AI score of 43/100 (low). Not financial advice.
How frequently does MMNFF data refresh on this page?
MMNFF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MMNFF's recent stock price performance?
MedMen Enterprises Inc. (MMNFF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand recognition in the cannabis industry. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MMNFF overvalued or undervalued right now?
Valuing MedMen Enterprises Inc. (MMNFF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MMNFF?
Before investing in MedMen Enterprises Inc. (MMNFF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC listing increases the risk of investing in MMNFF.
- AI analysis pending for MMNFF.